or Try an Advanced Search...

    Monoclonal Antibody Stocks List

    Symbol Grade Name % Change
    IMNM F Immunome, Inc. 0.96
    NAVB F Navidea Biopharmaceuticals, Inc. 0.00
    EQ F Equillium, Inc. 0.26
    ATNM F Actinium Pharmaceuticals, Inc. 5.76
    IPA F ImmunoPrecise Antibodies Ltd. -9.72
    ONCT F Oncternal Therapeutics, Inc. 1.75
    GMAB F Genmab A/S 0.10
    BIIB F Biogen Idec Inc. 1.29
    ZBIO F Zenas BioPharma, Inc. -16.14
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Long-Term Care Facilities
    Related Stock Lists: Immunology Antibodies Biotechnology Medicine Biopharmaceutical Monoclonal Antibodies Antibody Cancer Clinical Medicine Glycoproteins Immune System Multiple Sclerosis Acute Myeloid Leukemia Alzheimer's Disease Cd20 Chronic Lymphocytic Leukemia Clinical Development Iodine Lymphocytic Leukemia Lymphoma

    Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibody stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 6.54
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 4.14
    XPH B SPDR S&P Pharmaceuticals ETF 3.94
    YOLO F AdvisorShares Pure Cannabis ETF 3.63
    PJP D PowerShares Dynamic Pharmaceuticals 3.62
    View all Monoclonal Antibody ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare XPH to YOLO Compare YOLO to PJP

        Monoclonal Antibody Stocks Recent News

        Date Stock Title
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
        Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
        Nov 18 BIIB Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
        Nov 15 GMAB Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 BIIB Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
        Nov 15 IMNM Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Long-Term Care Facilities
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Medicine Immunology Antibodies Clinical Medicine Monoclonal Antibodies Cancer Clinical Development Drugs Host Disease Immune System Lymphoma Pharmaceutical Products Schizophrenia Specialty Drugs 3 D Acute Lymphoblastic Leukemia Adenosine
        Monoclonal Antibody

        A monoclonal antibody is a type of antibody that is made from a single clone of cells and is specific to a single antigen. Monoclonal antibodies are used in medical research and in the treatment of various diseases, such as cancer and autoimmune disorders. They are produced by fusing a single B-cell with a myeloma cell, which results in a hybrid cell that produces a single type of antibody. Monoclonal antibodies can be used to target specific antigens on cells, allowing researchers to study the function of the antigen and its role in disease. They can also be used to deliver drugs or toxins to specific cells, making them useful in cancer treatments.

        Browse All Tags